Camela, E. (2023) “Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire”, Dermatology Practical & Conceptual, 13(3), p. e2023177. doi:10.5826/dpc.1303a177.